Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.
Saved in:
| Title: | Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study. |
|---|---|
| Authors: | Hachulla, Eric1, Le Masson, Gwendal2, Solé, Guilhem2, Hamidou, Mohamed3, Desnuelle, Claude4, Azulay, Jean-Philippe5, Besson, Gérard6, Swiader, Laure7, Abad, Sébastien8, Antoine, Jean-Christophe9, Bouhour, Françoise10, Créange, Alain11, Grenouillet, Marike12, Magy, Laurent13, Marcel, Sébastien14, Paquet, Jean-Michel15, Rouhart, François16, Ziegler, François17, Mathis, Stéphane2, Gauthier-Darnis, Marc18 |
| Source: | BioMed Research International. 3/15/2018, Vol. 2018, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
